Edition:
United States

Arrowhead Pharmaceuticals Inc (ARWR.PH)

ARWR.PH on Philadelphia Stock Exchange

2.05USD
10:37am EDT
Change (% chg)

$0.03 (+1.23%)
Prev Close
$2.03
Open
$2.05
Day's High
$2.05
Day's Low
$2.05
Volume
100
Avg. Vol
3,417
52-wk High
$8.21
52-wk Low
$1.21

ARWR.PH

Chart for ARWR.PH

About

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $151.79
Shares Outstanding(Mil.): 74.77
Dividend: --
Yield (%): --

Financials

  ARWR.PH Industry Sector
P/E (TTM): -- 78.33 32.62
EPS (TTM): -0.67 -- --
ROI: -55.08 3.21 14.94
ROE: -61.13 5.08 16.18

BRIEF-Arrowhead Qtrly loss per share $0.07

* Qtrly revenue $9.3 million versus $39,583 Source text for Eikon: Further company coverage:

Aug 03 2017

BRIEF-Arrowhead reports Q2 revenue $9 million

* Q2 revenue $9 million versus $43,750 Source text for Eikon: Further company coverage:

May 03 2017

BRIEF-Arrowhead Pharmaceuticals adopts stockholder rights agreement

* Arrowhead Pharmaceuticals adopts stockholder rights agreement

Mar 23 2017

Earnings vs. Estimates